Original Research

Detection of Extended Spectrum Beta Lactamase Producing Enterobacteriaceae and Their Antibiotic Susceptibility Testing

DOI https://doi.org/10.70302/jpsim.v5i1.2415
Received: 06 Oct 2023 Accepted: 14 Dec 2023 Published Online: 28 Feb 2024

Abstract

Objective

To determine the antibiotic susceptibility pattern of Enterobacteriaceae and incidence of extended-spectrum beta-lactamases-producing Enterobacteriaceae.

Methods

This descriptive study consisted of a sample size of 200 Enterobacteriaceae isolates, was conducted in the Microbiology section of the Pathology department of Nishtar Medical University Multan from November 2020 to November 2021 . Blood, urine, and pus specimens were collected from patients of all age groups and either sex, after taking informed written consent. Identification was carried out by conventional biochemical tests and confirmed by Analytical Profile Index 20 E. Kirby-Bauer disc diffusion method was used to evaluate the sensitivity of bacterial isolates against different antibiotics. Identification of Extended Spectrum Beta Lactamase (ESBL) production was carried out by double-disc diffusion phenotypic confirmatory method.

Results

Among 200 culture-positive samples for Enterobacteriaceae, 77(38.5%) were from pus samples, 51(25.5%) were from blood and 72(36.0%) were from urine samples. The highest frequency of 111(55.5%) was identified as Eschercia coli. ESBL positive strains of enteric bacteria revealed in 29.5% of organisms. Patterns of drug susceptibility in ESBL negative showed highest resistance against Cefuroxime and Cefotaximeas 125/141 and 118/141 respectively while 59/59 for each in ESBL positive group.

Conclusion

A high proportion of ESBL- producing isolates belonging to Enterobacteriaceae were obtained from pus samples considering wound infections followed by urine and blood. The frequency of Eschercia coli remained the highest among ESBL and non-ESBL producer Enterobacteriaceae followed by Proteus and Enterobacter in this study. Meropenem and amikacin remained highly effective drugs for both groups followed by chloramphenicol and piperacillin/tazobactam.

Keywords
Resistance Antibiotic ESBL β-lactamases E. coli Enterobacteriaceae.

How to Cite This Article

Saeed J, Javaid A, Shabbir R, Ashfaq R, Neelam B, Malik S. Detection of Extended Spectrum Beta Lactamase Producing Enterobacteriaceae and Their Antibiotic Susceptibility Testing. J Pak Soc Intern Med. 2024;5(1):427–432. doi:10.70302/jpsim.v5i1.2415

Conflict of Interest

All authors declare no competing interests.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

No specific funding was received for this research.

Funder information follows the Crossref Funder Registry standard.

References

  1. Janda JM, Abbott SL. The changing face of the family enterobacteriaceae (order:“Enterobacterales”): New members, taxonomic issues, geographic expansion, and new diseases and disease syndromes. Clin Microbiol Rev. 2021;34(2):e00174-20.
  2. Bush K, Bradford PA. Interplay between β-lactamases and new β-lactamase inhibitors. Nat Rev Microbiol. 2019;17(5):295-306.
  3. Kumar D, Singh AK, Ali MR, Chander YJIDR, Treatment. Antimicrobial susceptibility profile of extended spectrum β-lactamase (esbl) producing escherichia coli from various clinical samples. 2014;7:IDRT. S13820.
  4. Castanheira M, Simner PJ, Bradford PA. Extended-spectrum β-lactamases: An update on their characteristics, epidemiology and detection. JAC-Antimicrob Resist. 2021;3(3):dlab092.
  5. Rezaei M, Akya A, Elahi A, Ghadiri K, Jafari S. The clonal relationship among the citrobacter freundii isolated from the main hospital in kermanshah, west of iran. Iranian journal of microbiology. 2016;8(3):175.
  6. Paudel P, Shrestha S, Poudel S, Tiwari BR. Multi-drug resistant bacteria isolated from pus and phenotypic detection of metallo β-lactamase activity of pseudomonas aeruginosa. Nepal J Health Sci. 2021;1(1):8-15.
  7. Ghafourian S, Sadeghifard N, Soheili S, Sekawi ZJCIiMB. Extended spectrum beta-lactamases: Definition, classification and epidemiology. 2015;17(1):11-22.
  8. Rottier WC, Ammerlaan HS, Bonten MJJJoAC. Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing enterobacteriaceae and patient outcome: A meta-analysis. 2012;67(6):1311-20.
  9. Mshana SE, Matee M, Rweyemamu MJAocm, antimicrobials. Antimicrobial resistance in human and animal pathogens in zambia, democratic republic of congo, mozambique and tanzania: An urgent need of a sustainable surveillance system. 2013;12(1):1-10.
  10. Farzana R, Shamsuzzaman S, Mamun K, Shears P. Antimicrobial susceptibility pattern of extended spectrum( beta-lactamase producing gram-negative bacteria isolated from wound and urine in a tertiary care hospital, dhaka city, bangladesh. Southeast Asian Journal of Tropical Medicine and Public Health. 2013;44(1):96-103.
  11. Teklu DS, Negeri AA, Legese MH, Bedada TL, Woldemariam HK, Tullu KD. Extended-spectrum beta-lactamase production and multi-drug resistance among enterobacteriaceae isolated in addis ababa, ethiopia. Antimicrob Resis Infect Control. 2019;8(1):1-12.
  12. Qadi M, Alhato S, Khayyat R, Elmanama AA. Colistin resistance among enterobacteriaceae isolated from clinical samples in gaza strip. Canad J Infect Dis Med Microbiol. 2021; https://doi.org/10.1155/2021/6634684. doi:10.1155/2021/6634684
  13. Tang H-J, Hsieh C-F, Chang P-C, Chen J-J, Lin Y-H, Lai C-C, et al. Clinical significance of community-and healthcare-acquired carbapenem-resistant enterobacteriaceae isolates. PLoS One. 2016;11(3):e0151897.
  14. Kateregga JN, Kantume R, Atuhaire C, Lubowa MN, Ndukui JG. Phenotypic expression and prevalence of esbl-producing enterobacteriaceae in samples collected from patients in various wards of mulago hospital, uganda. BMC Pharmacol Toxicolo. 2015;16(1):1-6.
  15. Kengne M, Dounia AT, Nwobegahay JM. Bacteriological profile and antimicrobial susceptibility patterns of urine culture isolates from patients in ndjamena, chad. Pan Afr Med J. 2017;28(1):258.
  16. Nanoty VV, Agrawal GN, Tankhiwale SS. Evaluation of antibiotic resistance and β-lactamase production in clinical isolates from a tertiary care hospital in central india. J Clin Basic Res. 2018;2(1):1-5.
  17. Yousefipour M, Rasoulinejad M, Hadadi A, Esmailpour N, Abdollahi A, Jafari S, et al. Bacteria producing extended spectrum β-lactamases (esbls) in hospitalized patients: Prevalence, antimicrobial resistance pattern and its main determinants. Iran J Pathol. 2019;14(1):61.
  18. Caron Y, Chheang R, Puthea N, Soda M, Boyer S, Tarantola A, et al. Beta-lactam resistance among enterobacteriaceae in cambodia: The four-year itch. Int J Infect Dis. 2018;66:74-9.
  19. Ouedraogo A-S, Sanou M, Kissou A, Sanou S, Solaré H, Kaboré F, et al. High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in burkina faso. BMC Infect Dis. 2016;16(1):1-9.
  20. Będzichowska A, Przekora J, Stapińska-Syniec A, Guzek A, Murawski P, Jobs K, et al. Frequency of infections caused by esbl-producing bacteria in pediatric ward–single center five-year observation. Arch Med Sci. 2019;15(3):688-93.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. © 2024 Journal of Pakistan Society of Internal Medicine.